Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.780
+0.020 (2.60%)
At close: Nov 20, 2024, 4:00 PM
0.746
-0.034 (-4.37%)
Pre-market: Nov 21, 2024, 7:14 AM EST
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $4.32 million as of November 21, 2024. Its market cap has decreased by -32.17% in one year.
Market Cap
4.32M
Enterprise Value
2.44M
1-Year Change
-32.17%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $4.32M, a decrease of -87.75%. That is a compound annual growth rate of -49.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 4.32M | 2.84% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 4.43M |
| Creative Medical Technology Holdings | 4.41M |
| Portage Biotech | 4.35M |
| Silo Pharma | 4.35M |
| Predictive Oncology | 4.29M |
| Sonoma Pharmaceuticals | 4.23M |
| Windtree Therapeutics | 4.09M |
| Hepion Pharmaceuticals | 4.02M |